The enzyme immunoassay test systems were developed using the obtained monoclonal antibodies highly specific for human fibrin and D-dimer, respectively, in the composition of an immunosorbent. The principle of the analysis is based on a bisite enzyme-linked immunosorbent assay with signal amplification due to the formation of a biotin-streptavidin-peroxidase complex. The absence of a cross-reaction of monoclonal antibodies that make up the immunosorbent with fibrinogen and other proteins of the blood coagulation system provides a high specificity of the test systems. Approved: in the leading clinics of Ukraine and received positive reviews and recommendations from a number of famous professors of these clinics. State registration received.
- high accuracy of the method;
- the uniqueness of the technology of the innovative product (the use of unique specific antibodies of our own production);
- low cost.
RECOMMENDED FIELD OF APPLICATION:
Medicine. Cardiology, surgery, vascular surgery, gynecology, oncology, endocrinology, traumatology, combustiology.
RESULTS OF THE RESEARCH:
Provides consistent results.
STAGE OF THE DEVELOPMENT READINESS:
Tested in trial operation.
Joint making available to industrial level.
2 patents of Ukraine.
IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,